Cargando…

P1206: GASTROINTESTINAL BLEEDING SIGNIFICANTLY REDUCED THE EFFICACY AND SURVIVAL OF CD19 CAR-T CELL THERAPY IN PATIENTS WITH GASTROINTESTINAL TRACT INVOLVEMENT OF REFRACTORY/RELAPSED B-CELL LYMPHOMA

Detalles Bibliográficos
Autores principales: Ma, L., Dou, Y., Liu, R., Xu, T., Yang, F., Xue, F., Zheng, P., Feng, S., Guo, Y., Shi, H., Deng, B., Ke, X., Hu, K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429101/
http://dx.doi.org/10.1097/01.HS9.0000847688.01787.13
_version_ 1784779329887010816
author Ma, L.
Dou, Y.
Liu, R.
Xu, T.
Yang, F.
Xue, F.
Zheng, P.
Feng, S.
Guo, Y.
Shi, H.
Deng, B.
Ke, X.
Hu, K.
author_facet Ma, L.
Dou, Y.
Liu, R.
Xu, T.
Yang, F.
Xue, F.
Zheng, P.
Feng, S.
Guo, Y.
Shi, H.
Deng, B.
Ke, X.
Hu, K.
author_sort Ma, L.
collection PubMed
description
format Online
Article
Text
id pubmed-9429101
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94291012022-08-31 P1206: GASTROINTESTINAL BLEEDING SIGNIFICANTLY REDUCED THE EFFICACY AND SURVIVAL OF CD19 CAR-T CELL THERAPY IN PATIENTS WITH GASTROINTESTINAL TRACT INVOLVEMENT OF REFRACTORY/RELAPSED B-CELL LYMPHOMA Ma, L. Dou, Y. Liu, R. Xu, T. Yang, F. Xue, F. Zheng, P. Feng, S. Guo, Y. Shi, H. Deng, B. Ke, X. Hu, K. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429101/ http://dx.doi.org/10.1097/01.HS9.0000847688.01787.13 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Ma, L.
Dou, Y.
Liu, R.
Xu, T.
Yang, F.
Xue, F.
Zheng, P.
Feng, S.
Guo, Y.
Shi, H.
Deng, B.
Ke, X.
Hu, K.
P1206: GASTROINTESTINAL BLEEDING SIGNIFICANTLY REDUCED THE EFFICACY AND SURVIVAL OF CD19 CAR-T CELL THERAPY IN PATIENTS WITH GASTROINTESTINAL TRACT INVOLVEMENT OF REFRACTORY/RELAPSED B-CELL LYMPHOMA
title P1206: GASTROINTESTINAL BLEEDING SIGNIFICANTLY REDUCED THE EFFICACY AND SURVIVAL OF CD19 CAR-T CELL THERAPY IN PATIENTS WITH GASTROINTESTINAL TRACT INVOLVEMENT OF REFRACTORY/RELAPSED B-CELL LYMPHOMA
title_full P1206: GASTROINTESTINAL BLEEDING SIGNIFICANTLY REDUCED THE EFFICACY AND SURVIVAL OF CD19 CAR-T CELL THERAPY IN PATIENTS WITH GASTROINTESTINAL TRACT INVOLVEMENT OF REFRACTORY/RELAPSED B-CELL LYMPHOMA
title_fullStr P1206: GASTROINTESTINAL BLEEDING SIGNIFICANTLY REDUCED THE EFFICACY AND SURVIVAL OF CD19 CAR-T CELL THERAPY IN PATIENTS WITH GASTROINTESTINAL TRACT INVOLVEMENT OF REFRACTORY/RELAPSED B-CELL LYMPHOMA
title_full_unstemmed P1206: GASTROINTESTINAL BLEEDING SIGNIFICANTLY REDUCED THE EFFICACY AND SURVIVAL OF CD19 CAR-T CELL THERAPY IN PATIENTS WITH GASTROINTESTINAL TRACT INVOLVEMENT OF REFRACTORY/RELAPSED B-CELL LYMPHOMA
title_short P1206: GASTROINTESTINAL BLEEDING SIGNIFICANTLY REDUCED THE EFFICACY AND SURVIVAL OF CD19 CAR-T CELL THERAPY IN PATIENTS WITH GASTROINTESTINAL TRACT INVOLVEMENT OF REFRACTORY/RELAPSED B-CELL LYMPHOMA
title_sort p1206: gastrointestinal bleeding significantly reduced the efficacy and survival of cd19 car-t cell therapy in patients with gastrointestinal tract involvement of refractory/relapsed b-cell lymphoma
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429101/
http://dx.doi.org/10.1097/01.HS9.0000847688.01787.13
work_keys_str_mv AT mal p1206gastrointestinalbleedingsignificantlyreducedtheefficacyandsurvivalofcd19cartcelltherapyinpatientswithgastrointestinaltractinvolvementofrefractoryrelapsedbcelllymphoma
AT douy p1206gastrointestinalbleedingsignificantlyreducedtheefficacyandsurvivalofcd19cartcelltherapyinpatientswithgastrointestinaltractinvolvementofrefractoryrelapsedbcelllymphoma
AT liur p1206gastrointestinalbleedingsignificantlyreducedtheefficacyandsurvivalofcd19cartcelltherapyinpatientswithgastrointestinaltractinvolvementofrefractoryrelapsedbcelllymphoma
AT xut p1206gastrointestinalbleedingsignificantlyreducedtheefficacyandsurvivalofcd19cartcelltherapyinpatientswithgastrointestinaltractinvolvementofrefractoryrelapsedbcelllymphoma
AT yangf p1206gastrointestinalbleedingsignificantlyreducedtheefficacyandsurvivalofcd19cartcelltherapyinpatientswithgastrointestinaltractinvolvementofrefractoryrelapsedbcelllymphoma
AT xuef p1206gastrointestinalbleedingsignificantlyreducedtheefficacyandsurvivalofcd19cartcelltherapyinpatientswithgastrointestinaltractinvolvementofrefractoryrelapsedbcelllymphoma
AT zhengp p1206gastrointestinalbleedingsignificantlyreducedtheefficacyandsurvivalofcd19cartcelltherapyinpatientswithgastrointestinaltractinvolvementofrefractoryrelapsedbcelllymphoma
AT fengs p1206gastrointestinalbleedingsignificantlyreducedtheefficacyandsurvivalofcd19cartcelltherapyinpatientswithgastrointestinaltractinvolvementofrefractoryrelapsedbcelllymphoma
AT guoy p1206gastrointestinalbleedingsignificantlyreducedtheefficacyandsurvivalofcd19cartcelltherapyinpatientswithgastrointestinaltractinvolvementofrefractoryrelapsedbcelllymphoma
AT shih p1206gastrointestinalbleedingsignificantlyreducedtheefficacyandsurvivalofcd19cartcelltherapyinpatientswithgastrointestinaltractinvolvementofrefractoryrelapsedbcelllymphoma
AT dengb p1206gastrointestinalbleedingsignificantlyreducedtheefficacyandsurvivalofcd19cartcelltherapyinpatientswithgastrointestinaltractinvolvementofrefractoryrelapsedbcelllymphoma
AT kex p1206gastrointestinalbleedingsignificantlyreducedtheefficacyandsurvivalofcd19cartcelltherapyinpatientswithgastrointestinaltractinvolvementofrefractoryrelapsedbcelllymphoma
AT huk p1206gastrointestinalbleedingsignificantlyreducedtheefficacyandsurvivalofcd19cartcelltherapyinpatientswithgastrointestinaltractinvolvementofrefractoryrelapsedbcelllymphoma